Limited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P50 Clinical Trial Optional)

The Intellectual and Developmental Disabilities Research Centers opportunity is offered by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, a component of the National Institutes of Health within the U.S. Department of Health and Human Services. The institute’s broader mission is to advance research and training that improves human development, reproductive health, and the well-being of children and individuals with disabilities. This funding opportunity continues a long-standing federal investment in research centers dedicated to intellectual and developmental disabilities, building on decades of scientific progress achieved through earlier center-based funding mechanisms. The purpose of this funding opportunity is to support multidisciplinary research centers that advance the diagnosis, prevention, treatment, and overall understanding of intellectual and developmental disabilities. The program invites applications in a limited competition format, meaning only currently funded centers under specified prior funding announcements are eligible to apply. The initiative emphasizes translational research, encouraging projects that bridge basic scientific discovery with clinical applications, including biomarker development, artificial intelligence tools, therapeutic interventions, and real-world evidence generation. Funded centers must include a structured combination of core facilities and research projects. Each center is required to establish three to four cores, including an Administrative Core and a Clinical Translational Core, which provide shared infrastructure and services to support both internal and externally funded research projects. In addition, each application must include two to three specific research projects aligned with identified priority areas. These projects are expected to be innovative, potentially high-risk, and capable of producing meaningful results within the defined project period. Funding is provided through a P50 Specialized Center mechanism with a maximum project duration of three years. The award budget allows up to eight hundred thousand dollars in direct costs per year, and the funding agency anticipates making up to fifteen awards, with total program funding estimated at approximately eighteen million dollars. While cost sharing is not required, applicants must demonstrate strong institutional support, including personnel, facilities, and collaborative infrastructure necessary to sustain a high-impact research environment. The application process requires submission through federal systems such as Grants.gov or the NIH ASSIST platform. Applicants must follow detailed multi-component application instructions, including separate sections for overall program strategy, individual cores, and research projects. Required components include a research strategy, budget justification, data management and sharing plan, and documentation of institutional commitment. Applications must comply with all formatting and submission requirements outlined in the NIH application guide, and failure to do so may result in rejection without review. Applications are evaluated through a rigorous peer review process that assesses scientific merit, innovation, feasibility, and overall impact. Review criteria include the strength of the research program, effectiveness of core facilities, quality of leadership and management, and the ability of the center to foster collaboration and advance the field. Additional emphasis is placed on integration across components, dissemination of findings, and support for early-career investigators. Only applications demonstrating strong potential for advancing knowledge and improving outcomes for individuals with intellectual and developmental disabilities will be considered for funding. Key dates for this opportunity include an application opening in early September and a submission deadline in early October. Following submission, applications undergo scientific review and advisory council evaluation, with funding decisions and project start dates occurring the following year. The program represents a final funding cycle under the current structure before a planned transition to a new model emphasizing clinical trial readiness, underscoring the importance of this opportunity for eligible institutions.

Emphasize integration across cores and projects; demonstrate strong translational impact; align research with stated priority areas; ensure strict compliance with NIH application instructions